Moreover, it could have provided insight into why abdominal lymph node metastases were negatively associated with OS or whether any of the patients in this cohort had metastases with low PSMA uptake but elevated glucose metabolism. This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.